Adar Poonawalla, CEO of Serum Institute of India, the country’s largest pharmaceutical company based in Pune, which is producing Oxford’s vaccine ‘Covishield’ in India in collaboration with Astragenica, said that before the second wave of Corona, 60 million vaccines were produced in countries around the world. had exported. He said that after the second wave of Corona, all the attention was shifted to the people of India as it was the need of the hour.
Adar Poonawalla at India Global Forum said on Wednesday- I don’t think things went in the wrong direction. Billions of dollars of vaccine are needed to meet the global supply. All the vaccine manufacturers in the world are working together because there is no other option. He said that we are increasing the production of the vaccine and others are also accelerating its pace.
Due to shortage, of course,there was always going to be a situation where countries will have to wait for some of the nations which could afford vaccine. That’s exactly where COVAX plays a role &we had in fact started to export lot of doses from India: Adar Poonawalla
(File pic) pic.twitter.com/gXuiTFi54V
— ANI (@ANI) June 30, 2021
The CEO of Serum further said – due to shortage, there is always a situation where some countries will have to wait due to some countries who can afford the vaccine. This is where COVAX plays a role and we actually started exporting a lot of supplements from India.
Poonawalla said that during January and February, we exported 60 million (60 million) vaccine doses, which was the highest for any country. After that the second wave of Corona knocked and after that all the attention had to be shifted to the people of India as it was the need of the time.
Also read: Serum CEO Adar Poonawalla has now issued this statement after allegations of threats regarding vaccine production